The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL - Concepedia

Concepedia

Publication | Open Access

The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL

DOI Full Paper Access

231

Citations

31

References

2009

Year

Unknown Author(s)

Journal of Neurology

Systemic SclerodermaImmunologyClinical TrialsNeurological ProgressNeurologySubgroup AnalysesMultiple SclerosisImmunotherapyMedicineNeuroimmunologyNovel Therapy

References

	Year	Citations

Page 1